OKX's proposal to tokenize shares from Apple and Meta has been rejected by both companies. The decisions lift the number of companies refusing similar plans to 67, a total spanning technology, finance, retail, industrials and healthcare.
Why it matters
Tokenizing a stock does not remove the need for issuer permission, and regulatory consent adds another layer of friction. The refusals are not confined to technology companies. Dell, IBM, KLA, Nike, Intel, AMD, Tesla, Oracle, Walmart, Boeing, JPMorgan and UnitedHealth Group are among those rejecting the plans, alongside Apple, Meta, Nvidia, Microsoft, Amazon and Goldman Sachs.
Market impact
For OKX, the immediate constraint is access to issuers, even as institutional adoption remains a broader crypto theme. Expanding tokenized-stock offerings now depends on specific approvals beyond the companies that have already refused. For crypto infrastructure providers, the episode reinforces the distinction between technical capability and market authorization. Technical readiness cannot substitute for company consent, which determines which assets can be offered.
Frequently asked questions
-
Why does issuer approval matter for tokenized-stock products?
Tokenizing a stock does not remove the need for issuer permission. The refusals show that company consent, alongside regulatory consent, is a central requirement for expanding OKX's proposed products.
-
How broad is the group of companies refusing OKX's proposals?
The 67-name list spans technology, finance, retail, industrials and healthcare. It includes Apple, Meta, Dell, IBM, Nike, Tesla, Nvidia, Microsoft, Amazon, JPMorgan and Goldman Sachs.
-
What does the rejection count mean for OKX's tokenization strategy?
Broad issuer consent has not been secured, so expanding the proposed offerings depends on additional company approvals. The 67 refusals show meaningful corporate and regulatory friction.
-
Can tokenization technology bypass regulatory and corporate limits?
No. Tokenizing a stock does not remove the need for issuer permission, while regulatory consent adds another layer of friction to the approval process.
-
What would investors watch next in the tokenized-stock market?
Specific issuer authorizations would mark a shift from the current rejection pattern. Until then, the relevant signal is whether the 67-company count rises or gives way to individual approvals.
WatcherGuru